2009Shiyong yixue zazhiRequires access

Study on rpoB mutation in rifampin resistants mycobacterium tuberculosis

Zhou Yon

Open publisher page 0 citations

Abstract

Objective To study the rpoB gene mutation in M.tuberculosis isolates,and evaluate their clinical value. Method 60 clinical isolates of mycobacterium tuberculosis were detected using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Results SSCP pattern of reference mycobacterium tuberculosis H37Rv as control, total mutation rate of 60 clinical isolates of mycobacterium tuberculosis is 53.3%(32/60), 4 stains mutation was round in rifampin-susceoitible 24 strains,mutation rate of 16.7%(4/24). SSCP patterns of rifampin resistant clinical isolates were different from the normal control, mutation rate of 77.8%(28/36) is higher than that of rifampin-susceoitible stains(P0.05). Conclusions The results confirm that rpoB gene mutation is the key mechanism in rifampin resistant tuberculosis mutation. It is feasible that using PCR-SSCP to detect drug resistance in mycobacterium tuberculosis.

About this research paper

What this paper is about

Objective To study the rpoB gene mutation in M.tuberculosis isolates,and evaluate their clinical value. Method 60 clinical isolates of mycobacterium tuberculosis were detected using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Results SSCP pattern of reference mycobacterium tuberculosis H37Rv as control, total mutation rate of 60 clinical isolates of mycobacterium tuberculosis is 53.3%(32/60), 4 stains mutation was round in rifampin-susceoitible 24 strains,mutation rate of 16.7%(4/24). SSCP patterns of rifampin resistant clinical isolates were different from the normal control, mutation rate of 77.8%(28/36) is higher than that of rifampin-susceoitible stains(P0.05). Conclusions The results confirm that rpoB gene mutation is the key mechanism in rifampin resistant tuberculosis mutation. It is feasible that using PCR-SSCP to detect drug resistance in mycobacterium tuberculosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the rpoB gene mutation in M.tuberculosis isolates,and evaluate their clinical value. Method 60 clinical isolates of mycobacterium tuberculosis were detected using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Results SSCP pattern of reference mycobacterium tuberculosis H37Rv as control, total mutation rate of 60 clinical isolates of mycobacterium tuberculosis is 53.3%(32/60), 4 stains mutation was round in rifampin-susceoitible 24 strains,mutation rate of 16.7%(4/24). SSCP patterns of rifampin resistant clinical isolates were different from the normal control, mutation rate of 77.8%(28/36) is higher than that of rifampin-susceoitible stains(P0.05). Conclusions The results confirm that rpoB gene mutation is the key mechanism in rifampin resistant tuberculosis mutation. It is feasible that using PCR-SSCP to detect drug resistance in mycobacterium tuberculosis.

Key concepts: rpoB, Mycobacterium tuberculosis, Single-strand conformation polymorphism, Tuberculosis, Biology, Microbiology, Mutation rate, Mutation

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on rpoB mutation in rifampin resistants mycobacterium tuberculosis — Research Paper | ScholarLens